Back to top
08071781188
Send SMS Send Inquiry
ErlotiRel
ErlotiRel

ErlotiRel

ErlotiRel Specification

  • Composition
  • Erlotinib Hydrochloride 150 mg per tablet
  • Weight
  • Approximately 200 mg per tablet
  • Feature
  • Targeted therapy drug for specific cancer mutations
  • Appearance
  • Oval-shaped tablet
  • Lead Time
  • 2-4 weeks
  • Precautions
  • Should not be used in patients with severe liver disease; must be taken on an empty stomach; avoid grapefruit products during medication.
  • Color
  • White
  • Product Type
  • Pharmaceutical Drug
  • Ingredients
  • Erlotinib Hydrochloride
  • Physical Form
  • Tablet
  • Treatments & Functions
  • Used for the treatment of non-small cell lung cancer and pancreatic cancer.
  • Recommended For
  • Cancer patients
  • Age Group
  • Adults
  • Dosage Guidelines
  • Typically administered at 150 mg once daily or as directed by a physician.
  • Quantity
  • 30 tablets per bottle
  • Packaging
  • HDPE bottles with child-resistant caps
  • Storage Instructions
  • Store at room temperature away from moisture and heat.
 
 

ErlotiRel About

As a distinguished supplier of the pharmaceutical industry, we are engaged in providing ErlotiRel. This tablet is procured from the certified vendors of the market. This tablet is processed by using highest quality compounds in compliance with medical standards of the industry. This tablet is recommended by the medical practitioners to treat the patients suffering from metastatic lung and pancreatic cancer. We supply these ErlotiRel at a reasonable price to the hospitals, clinics and chemist shops. 

Features:

  • Highly effective
  • Safe to consume
  • Longer shelf life


Effective Targeted Cancer Therapy

ErlotiRel is formulated specifically for adult cancer patients with certain genetic mutations. By targeting cancer cells more precisely than traditional chemotherapy, ErlotiRel offers improved outcomes with reduced side effects. Its mechanism focuses on blocking signals that allow cancer to grow and spread, making it a valuable choice in modern oncology care.


Safe and Secure Packaging

ErlotiRel is packaged in robust HDPE bottles fitted with child-resistant caps to ensure product safety and tapper integrity. Each bottle contains 30 tablets and is designed to protect the medication from moisture, heat, and accidental access, enhancing its suitability for clinical and home use alike.

FAQs of ErlotiRel:


Q: How should ErlotiRel be taken for optimal effectiveness?

A: ErlotiRel is most effective when taken on an empty stomach, typically once daily at a dose of 150 mg or as directed by your physician. Avoid grapefruit and related products while on this medication, as they can interfere with its absorption.

Q: What types of cancer is ErlotiRel used to treat?

A: ErlotiRel is primarily indicated for the treatment of adults with non-small cell lung cancer and pancreatic cancer. Consult your healthcare provider to confirm its suitability for your specific case.

Q: When is the best time to take ErlotiRel during the day?

A: ErlotiRel should be taken at the same time each day, ideally at least one hour before or two hours after eating, to maximize absorption and therapeutic benefits.

Q: Where should I store ErlotiRel tablets at home?

A: Store ErlotiRel at room temperature, away from moisture and heat. Keep the bottle securely closed and out of reach of children, thanks to its child-resistant cap.

Q: What is the process for obtaining ErlotiRel in India or abroad?

A: ErlotiRel can be sourced through registered distributors, exporters, suppliers, traders, and wholesalers in India. Speak with your healthcare provider or pharmacist about ordering, as lead time for delivery is typically 24 weeks.

Q: How does ErlotiRel benefit cancer patients compared to traditional treatments?

A: ErlotiRel acts by targeting specific mutations present in some cancer cells, potentially reducing tumor growth and spread with fewer side effects than conventional chemotherapy. This personalized approach can lead to improved outcomes for eligible patients.

Q: What precautions should be taken while using ErlotiRel?

A: Do not use ErlotiRel if you have severe liver disease. Always follow your physicians instructions, and avoid consuming grapefruit products. Report any unusual symptoms to your doctor promptly.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Reliance Life Science Category

ReliBeta

ReliBeta

Ingredients : Other , Beta Carotene Vitamin A

Weight : 0.5g per capsule

Product Type : Pharmaceutical Product, Other

Quantity : 30 capsules per bottle

Composition : Each capsule contains 15mg Beta Carotene and 5000 IU Vitamin A

Precautions : Consult a healthcare professional before use if pregnant nursing or taking medication

SynoLife - SynoLife One

SynoLife - SynoLife One

Ingredients : Other , Combination of vitamins minerals antioxidants and herbal extracts

Weight : Each capsule weighs 500mg

Product Type : Dietary Supplement, Other

Quantity : 30 capsules per bottle

Composition : Contains Vitamin A Bcomplex C D3 E zinc magnesium and proprietary herbal blend

Precautions : Consult a physician before use if pregnant nursing under medication or having any medical condition

ImmunoRel

ImmunoRel

Ingredients : Other , Vitamin C Zinc Echinacea Elderberry Extract

Weight : 0.5 grams per tablet

Product Type : Other , Dietary Supplement

Quantity : 60 tablets per bottle

Composition : Each tablet contains 500mg Vitamin C 25mg Zinc 50mg Echinacea Extract 50mg Elderberry Extract

Precautions : Consult a healthcare provider before use if pregnant nursing or taking other medications

HemoRel

HemoRel

Ingredients : Other , Iron Folic Acid Vitamin B12 Zinc

Weight : 500 mg per tablet

Product Type : Other , Health Supplement

Quantity : 30 tablets per bottle

Composition : Iron (as Ferrous Bisglycinate) Folic Acid Vitamin B12 Zinc Sulfate

Precautions : Consult a healthcare professional before use if pregnant nursing or on medication.